Synopsis
Synopsis
0
CEP/COS
0
JDMF
0
KDMF
0
VMF
0
Europe
0
Australia
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
Annual Reports
NA
1. 2-(diethylamino)ethyl 3-amino-4-propoxybenzoate
2. 2-(diethylamino)ethyl 3-amino-4-propoxybenzoate Monohydrochloride
3. Ak-taine
4. Alcaine
5. Benzoic Acid, 3-amino-4-propoxy-, 2-(diethylamino)ethyl Ester
6. Benzoic Acid, 3-amino-4-propoxy-, 2-(diethylamino)ethyl Ester, Monohydrochloride*benzoic Acid, 3-amino-4-propoxy-, 2-(diethylamino)ethyl Ester, Monohydrochloride
7. Chibro-kerakain
8. Kracaine
9. Kainair
10. Minims Proxymetacaine Hydrochloride
11. Ocu-caine
12. Ophthaine
13. Ophthetic
14. Parcaine
15. Proparacaine
16. Proparacaine Hcl
17. Proparakain-pos
18. Proxymetacaine
19. Proxymetacaine Hydrochloride
20. Proxymetacaine Monohydrochloride
21. Proxymethacaine
1. 5875-06-9
2. Proparacaine Hcl
3. Proxymetacaine Hydrochloride
4. Alcaine
5. 2-(diethylamino)ethyl 3-amino-4-propoxybenzoate Hydrochloride
6. Proparacaine, Hcl
7. Ophthaine
8. Ak-taine
9. Proparacaine (hydrochloride)
10. Kainair
11. Ophthetic
12. 2-(diethylamino)ethyl 3-amino-4-propoxybenzoate;hydrochloride
13. Nsc-759896
14. U96ol57goy
15. Dsstox_cid_28948
16. Dsstox_rid_83213
17. Dsstox_gsid_49022
18. Proparacaine Hydrochloride (usp)
19. Proparacaine Hydrochloride [usp]
20. Ophthain
21. 2-(diethylamino)ethyl 3-amino-4-propoxybenzoate Monohydrochloride
22. Benzoic Acid, 3-amino-4-propoxy-, 2-(diethylamino)ethyl Ester, Monohydrochloride
23. Smr000875264
24. Cas-5875-06-9
25. Ncgc00016991-03
26. Mfcd00083467
27. Keracaine
28. Chibro-heracaine
29. Ophthetic (tn)
30. Alcaine (tn)
31. Proparacainehydrochloride
32. Benzoic Acid, 3-amino-4-propoxy-, 2-(diethylamino)ethyl Ester, Hydrochloride
33. Unii-u96ol57goy
34. Schembl93880
35. Mls001333067
36. Mls001333068
37. Mls002154072
38. Chembl1200464
39. Dtxsid0049022
40. 2-diethylaminoethyl 3-amino-4-propoxybenzoate Hydrochloride
41. Hms1570p20
42. Pharmakon1600-01505688
43. Einecs 227-541-7
44. Tox21_113547
45. Nsc759896
46. S1828
47. Akos015844989
48. Tox21_113547_1
49. Ac-3399
50. Ccg-213513
51. Ks-5058
52. Nc00586
53. Nsc 759896
54. Proparacaine Hydrochloride [mi]
55. Benzoic Acid, 3-amino-4-propoxy-, 2-(diethylamino)ethyl Ester,monohydrochloride
56. Ncgc00016991-05
57. Hy-66012
58. Proparacaine Hydrochloride [vandf]
59. Proxymetacaine Hydrochloride, Proparacaine
60. Proparacaine Hydrochloride [usp-rs]
61. Proxymetacaine Hydrochloride [mart.]
62. P2156
63. Proxymetacaine Hydrochloride [who-dd]
64. Sw197338-3
65. Proparacaine Hydrochloride, Analytical Standard
66. C75748
67. D02098
68. Proparacaine Hydrochloride [green Book]
69. Proparacaine Hydrochloride [orange Book]
70. 875p069
71. A832009
72. Proparacaine Hydrochloride [usp Monograph]
73. 2-(diethylamino)ethyl 3-amino-4-propoxybenzoate Hcl
74. Sr-05000001759-3
75. Q27290947
76. 2-diethylaminoethyl3-amino-4-propoxy-benzoatehydrochloride
77. Benzoic Acid,3-amino-4-propoxy-,2-(diethylamino)ethyl Ester
78. Beta-(diethylamino)ethyl 3-amino-4-n-propoxybenzoate Hydrochloride
79. 3-amino-4-propoxybenzoic Acid 2-(diethylamino)ethyl Ester Hydrochloride
80. 2-(diethylamino)ethyl 3-amino-4-propoxy-benzoate Hydrochloride;proparacaine Hcl
81. Proparacaine Hydrochloride, United States Pharmacopeia (usp) Reference Standard
Molecular Weight | 330.8 g/mol |
---|---|
Molecular Formula | C16H27ClN2O3 |
Hydrogen Bond Donor Count | 2 |
Hydrogen Bond Acceptor Count | 5 |
Rotatable Bond Count | 10 |
Exact Mass | 330.1710204 g/mol |
Monoisotopic Mass | 330.1710204 g/mol |
Topological Polar Surface Area | 64.8 Ų |
Heavy Atom Count | 22 |
Formal Charge | 0 |
Complexity | 295 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 2 |
1 of 2 | |
---|---|
Drug Name | Proparacaine hydrochloride |
Drug Label | ALCAINE (proparacaine hydrochloride ophthalmic solution, USP) 0.5% is a topical local anesthetic for ophthalmic use. The active ingredient is represented by the structural formula:Established name:Proparacaine Hydrochloride Chemical name:Benzoic ac... |
Active Ingredient | Proparacaine hydrochloride |
Dosage Form | Solution/drops |
Route | Ophthalmic |
Strength | 0.5% |
Market Status | Prescription |
Company | Bausch And Lomb; Akorn |
2 of 2 | |
---|---|
Drug Name | Proparacaine hydrochloride |
Drug Label | ALCAINE (proparacaine hydrochloride ophthalmic solution, USP) 0.5% is a topical local anesthetic for ophthalmic use. The active ingredient is represented by the structural formula:Established name:Proparacaine Hydrochloride Chemical name:Benzoic ac... |
Active Ingredient | Proparacaine hydrochloride |
Dosage Form | Solution/drops |
Route | Ophthalmic |
Strength | 0.5% |
Market Status | Prescription |
Company | Bausch And Lomb; Akorn |
Anesthetics, Local
Drugs that block nerve conduction when applied locally to nerve tissue in appropriate concentrations. They act on any part of the nervous system and on every type of nerve fiber. In contact with a nerve trunk, these anesthetics can cause both sensory and motor paralysis in the innervated area. Their action is completely reversible. (From Gilman AG, et. al., Goodman and Gilman's The Pharmacological Basis of Therapeutics, 8th ed) Nearly all local anesthetics act by reducing the tendency of voltage-dependent sodium channels to activate. (See all compounds classified as Anesthetics, Local.)
API Imports and Exports
Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
---|
Upgrade, download data, analyse, strategize, subscribe with us
Related Excipient Companies
Excipients by Applications
Global Sales Information
Market Place
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
LOOKING FOR A SUPPLIER?